Kintor Pharmaceutical Limited (KNTPF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 135.69 Million CNY | -25.87% |
| 2022 | 183.05 Million CNY | 21.82% |
| 2021 | 150.26 Million CNY | 10.99% |
| 2020 | 135.39 Million CNY | 5758.5% |
| 2019 | 2.31 Million CNY | -90.65% |
| 2018 | 24.71 Million CNY | -17.61% |
| 2017 | 30 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 59.2 Million CNY | -55.62% |
| 2024 Q2 | 59.2 Million CNY | 0.0% |
| 2023 Q2 | 217.79 Million CNY | 0.0% |
| 2023 FY | 135.69 Million CNY | -25.87% |
| 2023 Q1 | 217.79 Million CNY | 18.98% |
| 2023 Q4 | 135.69 Million CNY | 0.0% |
| 2023 Q3 | 135.69 Million CNY | -37.7% |
| 2022 Q2 | 177.95 Million CNY | 0.0% |
| 2022 Q4 | 183.05 Million CNY | 0.0% |
| 2022 Q1 | 177.95 Million CNY | 18.43% |
| 2022 FY | 183.05 Million CNY | 21.82% |
| 2022 Q3 | 183.05 Million CNY | 2.86% |
| 2021 Q1 | 132.1 Million CNY | -2.43% |
| 2021 FY | 150.26 Million CNY | 10.99% |
| 2021 Q4 | 150.26 Million CNY | 0.0% |
| 2021 Q3 | 150.26 Million CNY | 13.75% |
| 2021 Q2 | 132.1 Million CNY | 0.0% |
| 2020 Q3 | 135.39 Million CNY | 36.16% |
| 2020 FY | 135.39 Million CNY | 5758.5% |
| 2020 Q1 | 99.43 Million CNY | 4202.73% |
| 2020 Q2 | 99.43 Million CNY | 0.0% |
| 2020 Q4 | 135.39 Million CNY | 0.0% |
| 2019 Q4 | 2.31 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 2.31 Million CNY | -90.65% |
| 2019 Q3 | 2.31 Million CNY | 0.0% |
| 2018 FY | 24.71 Million CNY | -17.61% |
| 2017 Q3 | 30 Million CNY | 0.0% |
| 2017 FY | 30 Million CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | 30 Million CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -548.955% |
| Evofem Biosciences, Inc. | 8000.00 USD | -1696025.0% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -7629.514% |
| Mesoblast Limited | 100.29 Million USD | -35.291% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -231287.06% |
| Genus plc | 228.2 Million USD | 40.539% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -20239.395% |
| ContraFect Corporation | 2.21 Million USD | -6039.819% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -9571.873% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -2400.516% |
| MultiCell Technologies, Inc. | 36.43 USD | -372467646.363% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -143.994% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -5995.687% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -10946.427% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | 18.311% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -7047.342% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -79144.291% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -2461619.884% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -395.245% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -42039.752% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 98.793% |
| Halberd Corporation | 150 Thousand USD | -90360.0% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -45130.0% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -82534.512% |
| argenx SE | 15.35 Million USD | -783.744% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -568.029% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -3045007.72% |
| Genscript Biotech Corporation | 287.12 Million USD | 52.743% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -107332.978% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -59078.075% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -24366.723% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -536245.31% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -1541.941% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -50981.371% |
| ONE Bio Corp. | 592.19 Thousand USD | -22812.945% |
| Reve Technologies, Inc. | 1064.00 USD | -12752719.549% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -90593.384% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -90593.384% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -58975.018% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -96134.043% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -169512.5% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -1635.175% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -36667.475% |
| International Stem Cell Corporation | 445 Thousand USD | -30392.135% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -1564.908% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -29591.466% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -11587.339% |
| PureTech Health plc | 18.25 Million USD | -643.507% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -90360.0% |
| IXICO plc | 275 Thousand USD | -49241.818% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -1046.127% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -415.755% |
| CSL Limited | 11.23 Billion USD | 98.793% |
| Cellectis S.A. | 36.21 Million USD | -274.719% |